Consider This from NPR Folgen

If President Trump knew how contagious and potentially deadly the coronavirus was back in February, why didn't he express that to the American public? That's the question Trump has been facing since last week, when a recording of him expressing a desire to "play down" the virus went public. The audio came from interviews with Washington Post journalist Bob Woodward that he conducted for his latest book, Rage. In an interview with NPR's Mary Louise Kelly, Woodward comes to the conclusion that the president failed to protect the country from the virus and is "the wrong man for the job."Listen to more of the Bob Woodward interview.Find and support your local public radio station.Email us at considerthis@npr.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

More than 3 million acres have burned in California this wildfire season. The previous record in a single season was 1.7 million, two years ago. Towns are being decimated across California, Oregon and Washington — and firefighting resources are maxed out, as NPR's Kirk Siegler reports from Boise, Idaho. In California, NPR's Lauren Sommer reports on an effort to fight fire with fire — something some Native American tribes have been doing for a long time.Find and support your local public radio station.Email us at considerthis@npr.orgLearn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

As trials continue for a coronavirus vaccine, some of the world's biggest drug companies have come together in an unusual way. This week, nine drugmakers released a joint statement pledging to not submit a coronavirus vaccine to the Food and Drug Administration unless it's shown to be safe and effective in large clinical trials. NPR's Sydney Lupkin reports that the statement comes as a commitment to science, at a time when some Americans have expressed concern that the trials are being rushed.Part of this concern comes from those who feel politics are influencing the processes vaccines must go through. The Centers for Disease Control and Prevention have told states a potential vaccine may be ready for distribution as soon as late October — right before Election Day. But when speaking with NPR's Mary Louise Kelly, Dr. Moncef Slaoui, chief scientific adviser to Operation Warp Speed, said there is a "very low chance" a vaccine will be ready by then. While some Americans are skeptical about a coronavirus vaccine, it doesn't seem like many of those people work on Wall Street. Each time a new vaccine trial phase is announced or a new scientific hurdle is cleared, drug company stock goes up. NPR's Tom Dreisbach reported that executives at one company took advantage of those rising stock prices.Find and support your local public radio station.Email us at considerthis@npr.orgLearn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy